Literature DB >> 20186122

Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.

Chantal Sellier1, Frédérique Rau, Yilei Liu, Flora Tassone, Renate K Hukema, Renata Gattoni, Anne Schneider, Stéphane Richard, Rob Willemsen, David J Elliott, Paul J Hagerman, Nicolas Charlet-Berguerand.   

Abstract

Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder caused by expansion of 55-200 CGG repeats in the 5'-UTR of the FMR1 gene. FXTAS is characterized by action tremor, gait ataxia and impaired executive cognitive functioning. It has been proposed that FXTAS is caused by titration of RNA-binding proteins by the expanded CGG repeats. Sam68 is an RNA-binding protein involved in alternative splicing regulation and its ablation in mouse leads to motor coordination defects. Here, we report that mRNAs containing expanded CGG repeats form large and dynamic intranuclear RNA aggregates that recruit several RNA-binding proteins sequentially, first Sam68, then hnRNP-G and MBNL1. Importantly, Sam68 is sequestered by expanded CGG repeats and thereby loses its splicing-regulatory function. Consequently, Sam68-responsive splicing is altered in FXTAS patients. Finally, we found that regulation of Sam68 tyrosine phosphorylation modulates its localization within CGG aggregates and that tautomycin prevents both Sam68 and CGG RNA aggregate formation. Overall, these data support an RNA gain-of-function mechanism for FXTAS neuropathology, and suggest possible target routes for treatment options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186122      PMCID: PMC2857464          DOI: 10.1038/emboj.2010.21

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers.

Authors:  A Kenneson; F Zhang; C H Hagedorn; S T Warren
Journal:  Hum Mol Genet       Date:  2001-07-01       Impact factor: 6.150

2.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.

Authors:  R J Hagerman; M Leehey; W Heinrichs; F Tassone; R Wilson; J Hills; J Grigsby; B Gage; P J Hagerman
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

3.  Transcription of the FMR1 gene in individuals with fragile X syndrome.

Authors:  F Tassone; R J Hagerman; W D Chamberlain; P J Hagerman
Journal:  Am J Med Genet       Date:  2000

4.  Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.

Authors:  F Tassone; R J Hagerman; D Z Loesch; A Lachiewicz; A K Taylor; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-09-18

5.  Signal-dependent regulation of splicing via phosphorylation of Sam68.

Authors:  Nathalie Matter; Peter Herrlich; Harald König
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

6.  RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.

Authors:  J P Venables; D J Elliott; O V Makarova; E M Makarov; H J Cooke; I C Eperon
Journal:  Hum Mol Genet       Date:  2000-03-22       Impact factor: 6.150

7.  The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites.

Authors:  O Stoss; M Olbrich; A M Hartmann; H Konig; J Memmott; A Andreadis; S Stamm
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

8.  hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.

Authors:  Yvonne Hofmann; Brunhilde Wirth
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

9.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

Authors:  C M Greco; R J Hagerman; F Tassone; A E Chudley; M R Del Bigio; S Jacquemont; M Leehey; P J Hagerman
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

10.  The germ cell nuclear proteins hnRNP G-T and RBMY activate a testis-specific exon.

Authors:  Yilei Liu; Cyril F Bourgeois; Shaochen Pang; Marek Kudla; Natacha Dreumont; Liliane Kister; Yong-Hua Sun; James Stevenin; David J Elliott
Journal:  PLoS Genet       Date:  2009-11-06       Impact factor: 5.917

View more
  198 in total

1.  Immune mediated disorders in women with a fragile X expansion and FXTAS.

Authors:  Isha Jalnapurkar; Nuva Rafika; Flora Tassone; Randi Hagerman
Journal:  Am J Med Genet A       Date:  2014-11-14       Impact factor: 2.802

Review 2.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

Review 3.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

Review 4.  Developments in RNA splicing and disease.

Authors:  Michael G Poulos; Ranjan Batra; Konstantinos Charizanis; Maurice S Swanson
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 5.  Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

Authors:  Huiping Tan; Zihui Xu; Peng Jin
Journal:  Exp Neurol       Date:  2012-01-27       Impact factor: 5.330

6.  Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching.

Authors:  Raman Parkesh; Jessica L Childs-Disney; Masayuki Nakamori; Amit Kumar; Eric Wang; Thomas Wang; Jason Hoskins; Tuan Tran; David Housman; Charles A Thornton; Matthew D Disney
Journal:  J Am Chem Soc       Date:  2012-03-05       Impact factor: 15.419

Review 7.  Small molecule targeting of RNA structures in neurological disorders.

Authors:  Alicia J Angelbello; Jonathan L Chen; Matthew D Disney
Journal:  Ann N Y Acad Sci       Date:  2019-04-09       Impact factor: 5.691

Review 8.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

9.  RNA-binding protein Sam68 controls synapse number and local β-actin mRNA metabolism in dendrites.

Authors:  Matthew E Klein; Thomas J Younts; Pablo E Castillo; Bryen A Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.

Authors:  Renate K Hukema; Ronald A M Buijsen; Chris Raske; Lies Anne Severijnen; Ingeborg Nieuwenhuizen-Bakker; Michelle Minneboo; Alex Maas; Rini de Crom; Johan M Kros; Paul J Hagerman; Robert F Berman; Rob Willemsen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.